Treatment of Coronavirus Disease 2019-Evidence-based or Personalized Medicine?

Fang, Ferric C; Schooley, Robert T

Fang, Ferric C; Schooley, Robert T.

Fang FC; Departments of Laboratory Medicine and Pathology, and Microbiology, University of Washington School of Medicine, Seattle, Washington, USA.
Schooley RT; Division of Infectious Diseases and Global Public Health, Center for Innovative Phage Applications and Therapeutics, University of California-San Diego, San Diego, California, USA.

Clin Infect Dis ; 74(1): 149-151, 2022 01 07.

Article in English | MEDLINE | ID: covidwho-1621568

Subject(s)

COVID-19; Antiviral Agents/therapeutic use; Humans; Precision Medicine; SARS-CoV-2

Keywords

COVID-19; SARS-CoV-2; clinical trials; evidence-based medicine; personalized medicine

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: Cid

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google